Average Co-Inventor Count = 4.86
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. 3-dimensional Pharmaceuticals, Inc. (30 from 76 patents)
2. Janssen Pharmaceutica Nv (26 from 2,078 patents)
3. Ortho-mcneil Pharmaceutical Corp. (4 from 363 patents)
4. Other (1 from 832,843 patents)
5. Janssen Biotech, Inc. (1 from 410 patents)
6. Dimensional Pharmaceuticals, Inc. (1 from 2 patents)
7. Johnson & Johnson Pharmaceuticals Research & Development, L.l.c. (1 from 1 patent)
64 patents:
1. 12404260 - Pyridine rings containing derivatives as MALT1 inhibitors
2. 12077521 - Pyrazole derivatives as MALT1 inhibitors
3. 11897880 - 7,8-dihydrobenzo[e]pyrido[3,4-c]azocine-2,5(3H,6H)-dione derivatives useful as a factor XIa inhibitors
4. 11814364 - Pyridine N-oxide derivatives useful as factor XIa inhibitors
5. 11472830 - Cyclic dinucleotides as sting agonists
6. 11098016 - Indazole derivatives useful as glucagon receptor antagonists
7. 11040031 - Pyrazole derivatives as MALT1 inhibitors
8. 10954214 - Pyrazole derivatives as MALT1 inhibitors
9. 10888550 - Pyrazole derivatives as MALT1 inhibitors
10. 10774048 - Indazole derivatives useful as glucagon receptor antagonists
11. 10413545 - Imidazolin-5-one derivative useful as FASN inhibitors for the treatment of cancer
12. 10214493 - Indazole derivatives useful as glucagon receptor antagonists
13. 10077261 - Imidazolin-5-one derivative useful as FASN inhibitors for the treatment of cancer
14. 10000473 - Indazole derivatives useful as glucagon receptor antagonists
15. 9718813 - Imidazolin-5-one derivative useful as FASN inhibitors for the treatment of cancer